MAPT and in situ carcinoma: The semiquantitative scoring of pathology using NFT Braak staging has been suggested to be a correlate of the CIS using FDG-PET (10), with CIS in DLB thought to be reflective of lower p-Tau pathological burden, although the intrinsic pathological basis of the CIS is unknown.